ask="12.84"
ask_size="100"
average_daily_volume="1981360"
bid="11.00"
bid_size="100"
book_value="-0.09"
change="-0.30"
change_from_200_day_moving_average="1.44"
change_from_50_day_moving_average="0.85"
change_from_52_week_high="-1.91"
change_From_52_week_low="5.29"
change_in_percent="-2.35%"
close="12.47"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94833000"
high="12.85"
high_52_weeks="14.38"
last_trade_date="2/10/2017"
last_trade_price="12.47"
last_trade_size="38373"
last_trade_time="4:00pm"
low="12.44"
low_52_weeks="7.18"
market_capitalization="1.60B"
moving_average_200_day="11.03"
moving_average_50_day="11.62"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.82"
pe_ratio="N/A"
peg_ratio="-0.27"
percent_change_from_200_day_moving_average="+13.08%"
percent_change_from_50_day_moving_average="+7.35%"
percent_change_from_52_week_high="-13.28%"
percent_change_from_52_week_low="+73.68%"
previous_close="12.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.23"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="9.08"
stock_exchange="NMS"
symbol="HALO"
volume="713194"
weeks_range_52="7.18 - 14.38"
